1. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Med 1998; 15:539-553.
2. Kumar PR, Bhansali A, Ravikiran M, Bhansali S, Dutta P, Thakur J, et al. Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: A community-based study. J Clin Endocr Metab 2010; 95:2832-2835.
3. Zakir M, Sultan K, Munir Y, Ahmad S, Amin S, Khan MA, et al. Biofunctional beverage: Antihyperglycemic effect of green tea in alloxan induced diabetic rabbits. Curr Bioact Compd 2019; 15:120-124.
4. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes 2008; 26:77-82.
5. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103:137-149.
6. Organization WH. Life course perspectives on coronary heart disease, stroke and diabetes: key issues and implications for policy and research: Summary report of a meeting of experts, 2-4 May 2001. World Health Organization, 2001.
7. Kato A, Hayashi E, Miyauchi S, Adachi I, Imahori T, Natori Y, et al. α-1-C-Butyl-1, 4-dideoxy-1, 4-imino-l-arabinitol as a second-generation iminosugar-based oral α-glucosidase inhibitor for improving postprandial hyperglycemia. J Med Chem 2012; 55:10347-10362.
8. Prabhakar P, Kumar A, Doble M. Combination therapy: A new strategy to manage diabetes and its complications. Phytomedicine 2014; 21:123-130.
9. Scheen AJ. Current management strategies for coexisting diabetes mellitus and obesity. Drugs 2003; 63:1165-1184.
10. Kim S-D. α-Glucosidase inhibitor isolated from coffee. J Microbiol Biotechnol 2015; 25:174-177.
11. Zafar M, Khan H, Rauf A, Khan A, Lodhi MA. In silico study of alkaloids as α-glucosidase inhibitors: Hope for the discovery of effective lead compounds. Front endocrinol 2016; 7:153.
12. Liu M, Zhang W, Wei J, Lin X. Synthesis and α-glucosidase inhibitory mechanisms of bis (2, 3-dibromo-4, 5-dihydroxybenzyl) ether, a potential marine bromophenol α-glucosidase inhibitor. Mar Drugs 2011; 9:1554-1565.
13. Subramanian R, Asmawi MZ, Sadikun A. In vitro alpha-glucosidase and alpha-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide. Acta Biochim Pol 2008; 55:391-398.
14. Ross SA, Gulve EA, Wang M. Chemistry and biochemistry of type 2 diabetes. Chem Rev 2004; 104:1255-1282.
15. Kim Y-M, Jeong Y-K, Wang M-H, Lee W-Y, Rhee H-I. Inhibitory effect of pine extract on α-glucosidase activity and postprandial hyperglycemia. Nutrition 2005; 21:756-761.
16. Matsui T, Yoshimoto C, Osajima K, Oki T, Osajima Y. In vitro survey of α-glucosidase inhibitory food components. Biosci Biotechnol Biochem 1996; 60:2019-2022.
17. Singh P, Jangra PK. Oxadiazoles: a novel class of anti-convulsant agents. Der Chemica Sinica 2010; 1:118-123.
18. Glomb T, Szymankiewicz K, Świątek P. Anti-cancer activity of derivatives of 1, 3, 4-oxadiazole. Molecules 2018; 23:3361.
19. Taha M, Ismail NH, Imran S, Rokei MQB, Saad SM, Khan KM. Synthesis of new oxadiazole derivatives as α-glucosidase inhibitors. Bioorg Med Chem 2015; 23:4155-4162.
20. De Oliveira CS, Lira BF, Barbosa-Filho JM, Lorenzo JGF, Athayde-Filho D, Filgueiras P. Synthetic approaches and pharmacological activity of 1, 3, 4-oxadiazoles: a review of the literature from 2000–2012. Molecules 2012; 17:10192-10231.
21. Yu W, Huang G, Zhang Y, Liu H, Dong L, Yu X, et al. I2-mediated oxidative C–O bond formation for the synthesis of 1, 3, 4-oxadiazoles from aldehydes and hydrazides. J Org Chem 2013; 78:10337-10343.
22. Fang T, Tan Q, Ding Z, Liu B, Xu B. Pd-catalyzed oxidative annulation of hydrazides with isocyanides: Synthesis of 2-amino-1, 3, 4-oxadiazoles. Org Lett 2014; 16:2342-2345.
23. Khalilullah H, J Ahsan M, Hedaitullah M, Khan S, Ahmed B. 1, 3, 4-oxadiazole: a biologically active scaffold. Mini Rev Med Chem 2012; 12:789-801.
24. Khurana JM, Sahoo PK, Maikap GC. Sonochemical esterification of carboxylic acids in presence of sulphuric acid. Synth Commun 1990; 20:2267-2271.
25. Aboraia AS, Abdel-Rahman HM, Mahfouz NM, El-Gendy MA. Novel 5-(2-hydroxyphenyl)-3-substituted-2, 3-dihydro-1, 3, 4-oxadiazole-2-thione derivatives: Promising anticancer agents. Bioorg Med Chem 2006; 14:1236-1246.
26. Pejin B, Iodice C, Tommonaro G, De Rosa S. Synthesis and biological activities of thio-avarol derivatives. J Nat Prod 2008; 71:1850-1853.
27. Patai S. Chemistry of cyanates and their thio derivatives: J. Wiley; 1977.
28. Sidoryk K, Michalak O, Kubiszewski M, Leś A, Cybulski M, Stolarczyk EU, et al. Synthesis of thiol derivatives of biological active compounds for nanotechnology application. Molecules 2020; 25:3470.
29. Hamdani SS, Khan BA, Ahmed MN, Hameed S, Akhter K, Ayub K, et al. Synthesis, crystal structures, computational studies and α-amylase inhibition of three novel 1, 3, 4-oxadiazole derivatives. J Mol Struct 2020; 1200:127085.
30. Rauf A, Banday MR, Mattoo RH. Synthesis, characterization and antimicrobial activity of long-chain hydrazones. Acta Chim Slov 2008; 55.
31. Kaplancikli ZA. Synthesis of some oxadiazole derivatives as new anticandidal agents. Molecules 2011; 16:7662-7671.
32. Shai L, Magano S, Lebelo S, Mogale A. Inhibitory effects of five medicinal plants on rat alpha-glucosidase: Comparison with their effects on yeast alpha-glucosidase. J Med Plant Res 2011; 5:2863-2867.
33. Kwon Y-I, Apostolidis E, Kim Y-C, Shetty K. Health benefits of traditional corn, beans, and pumpkin: in vitro studies for hyperglycemia and hypertension management. J Med Food 2007; 10:266-275.
34. Mosmann, Tim. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
35. Ragunath C, Manuel SG, Venkataraman V, Sait HB, Kasinathan C, Ramasubbu N. Probing the role of aromatic residues at the secondary saccharide-binding sites of human salivary α-amylase in substrate hydrolysis and bacterial binding. J Mol Biol 2008; 384:1232-1248.
36. Bhatia A, Singh B, Arora R, Arora S. In vitro evaluation of the α-glucosidase inhibitory potential of methanolic extracts of traditionally used antidiabetic plants. BMC Complement Altern Med 2019; 19:1-9.
37. Kannan S, Kolandaivel P. The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus. J Biomol Struct Dyn 2018; 36:4255-4269.
38. Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ. Computational protein–ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc 2016; 11:905-919.
39. Chipiti T, Ibrahim MA, Singh M, Islam MS. In vitro α-amylase and α-glucosidase inhibitory and cytotoxic activities of extracts from Cissus cornifolia planch parts. Pharmacogn Mag 2017; 13:S329.
40. Dineshkumar B, Mitra A, Manjunatha M. A comparative study of alpha amylase inhibitory activities of common anti-diabetic plants at Kharagpur 1 block. Int J Green Pharm 2010; 4.
41. Kotaiah Y, Harikrishna N, Nagaraju K, Rao CV. Synthesis and antioxidant activity of 1, 3, 4-oxadiazole tagged thieno [2, 3-d] pyrimidine derivatives. Eur J Med Chem 2012; 58:340-345.
42.Taha M, Imran S, Rahim F, Wadood A, Khan KM. Oxindole based oxadiazole hybrid analogs: Novel α-glucosidase inhibitors. Bioorg Chem 2018; 76:273-280.
43. Nair, Sindhu S., Vaibhavi Kavrekar, and Anshu Mishra. In vitro studies on alpha amylase and alpha glucosidase inhibitory activities of selected plant extracts. Eur J Exp Biol 2013; 3:128-132.
44. Saha R, Tanwar O, Marella A, Mumtaz Alam M, Akhter M. Recent updates on biological activities of oxadiazoles. Mini Rev Med Chem 2013; 13:1027-1046.
45. Zawawi NKNA, Taha M, Ahmat N, Ismail NH, Wadood A, Rahim F. Synthesis, molecular docking studies of hybrid benzimidazole as α-glucosidase inhibitor. Bioorg Chem 2017; 70:184-191.
46.Xiancui L, Rongli N, Xiao F, Lijun H, Lixin Z. Macroalage as a source of alpha-glucosidase inhibitors. Chin J Oceanol Limnol 2005; 23:354-356.